Atlas Trials

Feraheme As An MRI Contrast Agent For Pediatric Congenital Heart Disease

Clinical trial NCT02752191 · COMPLETED

Trial details

NCT number
NCT02752191
Sponsor
Paul Finn
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Pediatric Congenital Heart Disease
Start date
2016-04-01
Primary completion
2018-12-19
Enrollment
17

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.